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Abstract 
Trends in the Rate of Inpatient Pediatric Bipolar Disorder Diagnosis between 
1996 and 2015 
by 
Samantha Sherwood 
Dr. Andrew Freeman, Committee Chair 
Assistant Professor of Psychology 
University of Nevada, Las Vegas 
The rate of PBD in the U.S. increased dramatically between the mid-1990s and mid-2000s 
resulting in concern regarding the potential for misdiagnosis of PBD. However, given that the 
rate of PBD diagnosis had not been examined in the U.S. since 2004, the longitudinal trajectory 
of PBD diagnosis subsequent to the mid-2000s was unclear. Therefore, the present study utilized 
two datasets of administrative billing claims to assess whether longitudinal changes in the rate of 
inpatient PBD diagnosis continued to occur subsequent to 2004. Study 1 utilized a nationally 
representative dataset of inpatient psychiatric hospitalizations between 1996 and 2010. De-
identified data were obtained from the National Hospital Discharge Survey (NHDS) conducted 
annually by the National Center for Health Statistics. Study 2 utilized a state-level database of 
de-identified Medicaid billing claims between 2005 and 2015. Data included youth ages five to 
17 hospitalized at one of five psychiatric inpatient hospitals in Nevada during the study period. 
Results indicated that the proportion of PBD diagnoses to all psychiatric diagnoses increased 
between 1996 and 2004 among children and adolescents. The proportion of PBD diagnoses then 
decreased between 2004 and 2010 among children but continued to increase for adolescents. 
However, the population-adjusted rates of PBD diagnosis per 10,000 individuals in the general 
population initially increased until the mid-2000s and then decreased until 2010 for all age 
iv 
groups. State-level data indicated a decline in the rate of PBD diagnosis between 2005 and 2015. 
Findings provide insight into changing trends in inpatient service utilization for BD in the U.S. 
Awareness of the current diagnostic trends for BD may assist inpatient administrators and 
clinicians in preparing for anticipated service utilization and planning allocation of resources. 
Further research is necessary to evaluate continuously changing diagnostic rates and to determine 
the exact causes of changing trends in diagnosis across time. 
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Chapter 1: Literature Review 
Bipolar disorder (BD) is a severe and chronic illness marked by episodic changes in 
mood. BD is among the leading causes of disability worldwide because it is associated with a 
high rate of impairment (Lopez & Murray, 1998) and increased mortality due to substantial 
increase in suicide risk relative to the general population (Schaffer et al., 2015). Most adults with 
BD retrospectively report initial onset of mood symptoms in childhood or adolescence (e.g., 
(Chengappa et al., 2003; Goodwin & Jamison, 2007; Perlis et al., 2004) with the typical period 
of onset between 18 to 22 years (Merikangas et al., 2007; Weissman et al., 1996). However, 
pediatric bipolar disorder (PBD), or BD that onsets prior to age 18, was considered extremely 
rare until very recently (Fristad & Algorta, 2013). Opinions regarding the prevalence of PBD 
began to change when long-term follow-up of children treated for unipolar depression indicated 
approximately 30% converted from unipolar depression to BD (Geller, Fox, & Clark, 1994) and 
two larger cohorts of youth with PBD were prospectively identified in the early 1990s 
(Biederman et al., 1996; Geller, Fox, & Fletcher, 1993). Over the next decade, the rate of clinical 
diagnosis of PBD increased dramatically (Blader & Carlson, 2007; Moreno et al., 2007). The rate 
of PBD diagnosis in the U.S. has not been examined since 2004, and it is unknown whether the 
rate of diagnosis has stabilized, declined, or continued to increase since the mid-2000s. 
Therefore, the purpose of the current paper is to examine whether the rate of clinical diagnosis of 
PBD has continued to increase over the past decade. 
PBD has been identified in the clinical literature for centuries. In the early 20th century, 
Kraepelin described bipolar disorder as frequently occurring between ages 15 and 20 (Kraepelin, 
1921). Throughout the 1970s and 1980s, case studies and case series identified youth with PBD. 
The identification of youth in only case studies led many to believe that PBD was exceedingly 
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rare (Carlson & Glovinsky, 2009). The subsequent increase in the rate of diagnosis in the mid-
1990s to mid-2000s caused many to believe that PBD was being over-diagnosed (Hirschfeld, 
Lewis, & Vornik, 2003; Jenkins, Youngstrom, Washburn, & Youngstrom, 2011). As a result of 
this worry, the DSM-5 introduced the new diagnosis of disruptive mood dysregulation disorder 
(American Psychiatric Association, 2013) to potentially decrease the diagnosis of PBD in 
clinical settings. However, large increases in clinical diagnoses can occur for many reasons. First 
and foremost, changes in genetic, biological, or environmental risk factors may occur and can 
result in both increases and decreases in prevalence. Besides true changes in prevalence, the rate 
of diagnosis can also increase if case-finding improves due to clinician awareness. Prevalence 
may also increase due to changes in (a) diagnostic definitions and standards; (b) diagnostic 
substitution; and (c) changes in availability of services (i.e., FDA approved medicine). The 
precise reason for why a change in prevalence is occurring can be difficult to ascertain unless 
certain conditions are met. 
Change in the Rate of PBD Diagnosis 
Outpatient. 
Most studies examining the rate of change of PBD diagnosis in the United States 
examined changes between approximately 1994 and 2004. For example, between 1995 and 2000 
the rate of outpatient billing claims for PBD increased from 90 to 150 per 10,000 billing claims 
in a nationally representative sample of private insurance claims for youth 0 to 18 years (Harpaz-
Rotem & Rosenheck, 2004). Analysis of the National Ambulatory Medical Care Survey, a 
random sampling of U.S. outpatient physicians, assessed rates of PBD diagnosis between 1994 
and 2003 and found an increase in diagnosis from 2.5 to 100.3 per 10,000 population among 
outpatient youth ages 0 to 19 (Moreno et al., 2007). Additionally, the percentage of outpatient 
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visits with a diagnosis of PBD increased from .01% to .44% out of the total outpatient visits. 
Analyses based on private insurance data indicate an almost doubling of risk of PBD diagnosis, 
while the more comprehensive national data suggests risk increased approximately forty-fold. In 
summary, the rate of outpatient PBD diagnoses increased over a ten-year period. 
Inpatient. 
An increase in the rate of clinical diagnosis of PBD also occurred in inpatient units 
during the same time period. In a sample of privately insured youth admitted to inpatient 
psychiatric facilities, the rate of PBD diagnosis increased from 1,060 to 1,840 per 10,000 youth 
between 1995 and 2000 (Harpaz-Rotem, Leslie, Martin, & Rosenheck, 2005). Blader and 
Carlson (2007) examined rates of BD diagnosis among inpatient children, adolescents, and adults 
between 1996 and 2004, using discharge rates from the National Hospital Discharge Survey. 
Results indicated that the rate of PBD diagnosis among children ages 5 to 13 increased from 1.3 
to 7.3 per 10,000. The rate of PBD diagnosis among adolescents ages 14 to 18 increased from 
5.1 to 20.4 per 10,000. The increase in the rate of BD diagnosis was significantly greater among 
youth than the increase for adults. Furthermore, hospitalization was more prevalent in this 
sample among male compared to female children (ages 5 to 13), but by adolescence (ages 14 to 
18) hospitalization was more prevalent among females compared to males. The rate of diagnosis
of PBD also increased by 1.9 times in youth with private insurance (Blader & Carlson, 2007). 
Similar to outpatient data, the rate of diagnosis of PBD in U.S. inpatient units increased over the 
same decade but at a higher rate. 
Research on changing trends in diagnostic rates using samples from the U.S. ended at the 
peak of the PBD diagnostic phenotype debate. Many European scholars have argued that PBD 
was an American concern (James et al., 2014; Parry & Richards, 2014). However, two analyses 
 4 
using data from the nationwide German inpatient healthcare system examined continued change 
in rates of PBD diagnosis between 2000 and 2013 (Holtmann et al., 2010; Rao et al., 2016). 
Holtmann and colleagues (2010) identified an increase from 0.113 to 0.191 per 10,000 in PBD 
diagnosis between 2000 and 2007 among hospitalized youth under age 19 years. Change in the 
PBD diagnostic rate varied by age with younger youth (< 15 years) displaying no change in the 
rate of PBD diagnoses but older adolescents (15-19 years) displaying a large increase in the rate 
of PBD diagnoses. Rao and colleagues (2016) subsequently compared these findings with data 
from the same nationwide inpatient database to determine continued change between 2008 and 
2013. The rate of diagnosis of PBD in children (< 15 years) did not significantly increase (0.2 to 
0.3 per 100,000), while the rate of diagnosis among older adolescents (15 – 19 years) increased 
from 6.56 to 8.14 per 100,000 adolescents. Proportionally, the rate of PBD diagnosis increased 
from 0.26 to 0.27 of all psychiatric diagnosis in the German inpatient healthcare system between 
2008 and 2013 (Rao et al., 2016). These findings suggest either: (a) risk factors for PBD are 
changing in Germany as well as the U.S., or (b) if one assumes that earlier U.S. increases also 
apply to Germany then the rate of PBD diagnosis has also increased. Of note, the German 
healthcare system is markedly different from the U.S. health care system, and provider incentives 
for diagnosis are likely to differ dramatically (Stringaris & Youngstrom, 2014). Therefore, it is 
possible that trends in the rate of PBD diagnosis may have differed between the U.S. and 
Germany over the past decade. 
Implications. 
Findings regarding the increase in PBD diagnosis were presented in terms of relative risk 
at the time of publication. For example, Moreno and colleagues (2007) indicated a 40-fold 
increase in the proportion of office visits for PBD (i.e., 0.01 to 0.44%) as a proportion of all 
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outpatient office visits.  The presentation of this finding as a 40-fold increase in the proportion of 
office visits for PBD led to concerns about the potential over-diagnosis of PBD. However, when 
considered in terms of absolute risk, a 40-fold increase from 0.01% is quite small. Furthermore, 
this increase was not considered within the context of broader epidemiological findings. In 
particular, the epidemiological base rate for the spectrum of pediatric bipolar disorders has been 
estimated at 1.8%, with the prevalence rate rising to 2.7% when considering only youth age 12 or 
older (Van Meter, Moreira, & Youngstrom, 2011). While the rate of PBD diagnosis per 10,000 
youth increased dramatically between the mid-1990s to mid-2000s, this rate still remained below 
the estimated epidemiological base rate of PBD. Changes in the rate of inpatient PBD diagnosis 
identified by Blader and Carlson (2007) also remained below the estimated epidemiologic base 
rate of PBD. While PBD diagnosis increased between 1996 and 2004, the risk of PBD diagnosis 
associated with an outpatient visit remained well below what would be expected given 
epidemiological base rates. Therefore, a portion of youth with PBD identified in epidemiological 
samples may still not have received services during this time. 
Changes in Diagnostic Rates of Other Disorders 
 Much of the concern regarding the increase in PBD diagnosis views the increase in 
relative isolation. However, other pediatric psychiatric disorders have seen changes in diagnostic 
rates similar to or greater than PBD. For example, between 2000 and 2007, an increase in 
depressive disorder diagnosis from 1.3 to 4 per 10,000 admissions was identified for youth ages 
0 to 19 using data from the German inpatient healthcare system (Holtmann et al., 2010). A 
follow up to this study compared data collected between 2008 and 2013 with the original data 
collected between 2000 and 2007 and identified a total increase from 1.3 to 10.4 per 10,000 
admissions in the rate of depressive disorder diagnosis between 2000 and 2013 (Rao et al., 
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2016). During this time period, the rate of diagnosis of depression in youth increased 
approximately eightfold, relative to twofold for PBD. Therefore, clinicians working in inpatient 
psychiatric units might be diagnosing all mood disorders in youth more frequently.  
While it is possible that clinicians are simply more willing to diagnose mood disorders, it 
is also possible that the stigma associated with the use of more severe diagnoses has decreased 
and clinicians have become more willing to use diagnoses indicating more severe 
psychopathology. For example, in the same dataset used to identify change in the rate of PBD 
diagnosis, Blader and Carlson (2007) also identified a significant increase in the rate of diagnosis 
of conduct-related disorders between 1996 and 2004. In particular, the rate of diagnosis of 
conduct-related disorders increased by 6.2% among children and 12% among adolescents 
nationally during this time period (Blader & Carlson, 2007). Therefore, the increase in PBD 
diagnosis may simply reflect an increase in clinicians’ willingness to diagnose more severe 
psychopathology in inpatient units. 
Reasons for Changes in Prevalence Rates 
The increased prevalence of PBD in clinical settings has stirred substantial debate 
regarding the appropriate diagnosis of BD in children and adolescents. For example, the DSM-5 
included disruptive mood dysregulation disorder with the hopes of decreasing PBD diagnosis in 
children and adolescents (American Psychiatric Association, 2013). However, the changes in the 
rate of PBD diagnosis should be considered in the greater context of the identification of 
disorders and diseases. Cancer and autism spectrum disorders (ASD) provide two worthwhile 
comparators because the epidemiological surveillance of the clinical prevalence of both illnesses 
has greater longevity than PBD. The clinical diagnosis of some subtypes of cancer have 
increased while others have decreased in the prior two decades. For example, the clinical 
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prevalence of prostate cancer diagnosis increased dramatically from a relatively undiagnosed, 
unrecognized disease to a more easily identified illness with the introduction of PSA screening. 
Similarly, the rate of ASD diagnosis increased between 7.5 and 15 fold between 1966 and the 
early 2000s (4 per 10,000 to 30 – 60 per 10,000; Fombonne, 2003; Rutter, 2005). Therefore, the 
changes in the clinical prevalence of PBD diagnosis may not be due to over-diagnosis, but 
reflective of broader changes related to clinical service provision, such as increased availability 
of effective screening tools. 
In both cancer and ASD surveillance, the reasons for changes in the clinical prevalence of 
the illnesses have been given substantially greater thought than in PBD. In particular, changes in 
the rate of screening, classification, and risk exposure are likely causes of changes in the 
prevalence of cancer (Ward, Thun, Hannan, & Jemal, 2006). For example, improved 
classification of esophageal cancers by cell type instead of bodily region indicated that while the 
overall prevalence of esophageal cancers has increased slightly, some types (e.g., squamous cell 
carcinoma) decreased while other types increased (e.g., adenocarcinoma; Vizcaino, Moreno, 
Lambert, & Parkin, 2002). Exposure to risk factors also affects the true rate of illness. For 
example, as the prevalence of smoking has decreased, so too has the prevalence of lung cancers 
(Govindan et al., 2006). However, for illnesses not clearly marked by definable biological tests 
such as ASD and PBD, additional factors might also play a role in the rate of change of 
diagnosis. In addition to changes in the screening, classification, and risk factors, mental health 
diagnoses are also likely subject to changes in the availability of services, pattern of referrals, 
increased public awareness, and changes in diagnostic definitions (Fombonne, 2003). For 
example, many ASD observers believe that the increase in the rate of autism diagnosis is most 
likely due to external factors related to service provision, awareness, and changes in diagnostic 
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definitions and not directly due to a large increase in the actual incidence of autism from changes 
in risk factors (Hansen, Schendel, & Parner, 2015; Rutter, 2005). Therefore, if PBD experienced 
a period of a broader diagnostic definition, increased awareness, and an increase in the 
availability of assessment tools and interventions, then an increase in the clinical diagnosis of 
PBD should be expected. At the same time that the clinical prevalence of PBD increased from 
the mid-1990s to the mid-2000s, all of these external risk factors occurred making it more 
difficult to link the change in PBD diagnostic rates to any specific reason for such a change.  
Changes in the Diagnostic Standard. 
BD in adults is defined as an illness of distinct episodes with changes in mood and energy 
(American Psychiatric Association, 2013; World Health Organization, 1992). Despite diagnostic 
manuals and many textbooks implying that adults with BD present with distinct mood episodes 
separated by periods without mood symptoms, approximately half of adults with BD have 
subthreshold symptoms between mood episodes (Perlis et al., 2006). Similarly, most youth with 
PBD present with subthreshold symptoms between episodes (Birmaher, Axelson, Goldstein, et 
al., 2009; Birmaher et al., 2006; DelBello, Hanseman, Adler, Fleck, & Strakowski, 2007; Geller, 
Tillman, Bolhofner, & Zimerman, 2008). Early work examining the phenotype of PBD 
emphasized its chronic course (Birmaher et al., 2006). One such instantiation is the ‘broad’ 
phenotype of PBD. The ‘broad’ phenotype emphasized chronic presentation marked by the 
presence of severe, chronic irritability (Biederman et al., 2004). While the broad phenotype 
garnered clinical support because it represents a set of severely dysregulated and impaired youth, 
the lack of distinct episodes concerned many. The broad phenotype represented a non-episodic 
presentation in contrast to the historical description of BD as an episodic syndrome. 
Additionally, the broad phenotype focused on the presence of severe irritability as the principal 
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symptom of mania and youth did not need to present with more specific symptoms of mania such 
as grandiosity, elated mood, or decreased need for sleep (Leibenluft, Charney, Towbin, Bhangoo, 
& Pine, 2003; Youngstrom, Birmaher, & Findling, 2008). The potential symptoms of mania that 
were also symptoms of other disorders (e.g., irritability, increased energy) led to concerns about 
misdiagnosis of PBD. Therefore, a ‘narrow’ phenotype was proposed as a more restricted 
alternative to the broad phenotype. 
The narrow phenotype of PBD focuses on the presence of specific symptoms of mania. 
The narrow phenotype requires elated mood or grandiosity and typically also requires the 
presence of a clear episode which lasts for a period of at least one week (Geller et al., 2002; 
Leibenluft et al., 2003). Under this phenotype, irritable mood is insufficient on its own to meet 
criteria for mood disturbance in the narrow phenotype because irritability could arise due to 
many different presenting concerns. The use of an “and” rule and the exclusion of irritability as a 
symptom of mania creates a more restrictive definition that may ignore a subset of cases (Sharma 
et al., 2016; Washburn, West, & Heil, 2011). Therefore, an ‘intermediate’ phenotype attempted 
to compromise between the narrow and broad definitions of pediatric mania. 
The intermediate phenotype is consistent with DSM and International Classification of 
Diseases (ICD; World Health Organization, 1992) diagnostic criteria. The intermediate 
phenotype also includes the entire spectrum of BD (i.e., bipolar I, bipolar II, cyclothymia, and 
OSBARD) by accounting for even brief duration episodes of manic symptoms such as 1-3 days. 
The intermediate phenotype also includes irritable mood as a cardinal symptom of mania even if 
no elevated mood is present, as long as duration and other diagnostic criteria are met (Leibenluft 
et al., 2003; Pavuluri, Birmaher, & Naylor, 2005). Research using the intermediate phenotype 
indicates that characteristics of PBD are generally consistent with adult presentations of BD 
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except that youth with PBD tend to have longer duration episodes and more irritable mood 
(Youngstrom, Birmaher, & Findling, 2008). Additionally, youth with PBD often exhibit high 
levels of functional impairment (Freeman et al., 2009) and have a family history of mood 
disorders (Birmaher et al., 2006).  
While some differences between PBD and adult BD exist, substantial overlap between 
the two diagnoses has been identified. A meta-analysis of 20 studies of PBD phenomenology 
indicated that approximately 79% of youth with PBD presented with increased energy, 57% had 
grandiosity, and other symptoms of mania ranged from being present in 54% to 77% of youth 
with PBD (Van Meter, Burke, Kowatch, Findling, & Youngstrom, 2016). This continuity 
between child and adult phenotypes of BD suggests that the clinical presentation of PBD may be 
similar to adult BD for many youths. As a result, a consensus around a DSM-oriented model of 
PBD using the intermediate phenotype has recently developed (Carlson & Glovinsky, 2009; 
Robert A. Kowatch, Youngstrom, Danielyan, & Findling, 2005; Van Meter et al., 2016). Prior to 
this consensus, the debate surrounding the PBD phenotype may have influenced the criteria used 
to diagnose PBD in clinical practice. Clinicians may have based diagnoses on either the broad, 
narrow, or intermediate phenotypes. In particular, if clinicians used the broad phenotype during 
this time, the rate of diagnosis of PBD would be expected to increase because the broad 
phenotype substantially expanded diagnostic criteria. Given these concerns, questions arose 
about the extent to which the rate of clinical PBD diagnosis had changed prior to the resolution 
of the phenotype debate. 
Changes in Awareness. 
From the mid-1990s to the mid-2000s, there was a dramatic increase in public awareness 
related to the PBD diagnosis (Lofthouse & Fristad, 2004). One metric of public awareness is 
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how often a term is searched on the internet. Google trends suggests bipolar disorder is being 
searched less often since the mid-2000s than prior to the mid-2000s (Fond, Gaman, Brunel, 
Haffen, & Llorca, 2015), suggesting that heightened public awareness of PBD prior to the mid-
2000s likely occurred simultaneously with the increase in the rate of diagnosis of PBD. Similar 
increases in awareness have been observed for other psychiatric disorders. For example, the rate 
of ASD diagnosis has continued to increase concurrently with the increase in public awareness 
about the disorder. While public searching for BD has decreased since the mid-2000s, Google 
trends indicates that public searching for ASD has remained relatively stable and the rate of 
diagnosis of ASD has continued to increase. It is possible that the rate of diagnosis of PBD has 
not continued to increase in the same manner given the decline in public awareness of BD since 
the mid-2000s. Therefore, it is important to assess the rate at which PBD has been diagnosed 
over the past decade to determine whether there is need for concern regarding continued increase 
of PBD diagnosis. 
Changes in Assessment Methods. 
Development of effective screening tools can have a substantial impact on the rate at 
which an illness is diagnosed (e.g., as in cancer and ASD diagnosis). Prior to the mid-1990s, 
evidence-based assessment tools for diagnosing PBD were limited. As part of the increased 
scientific awareness of PBD, researchers focused on improving methods for assessing PBD. 
These advances included structured and semi-structured clinical interviews, self-report measures 
and informant-report measures with questions specifically designed to assess mania symptoms. 
For example, the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS; Puig-
Antich & Chambers, 1978), a semi-structured interview initially developed in the 1970s to assess 
for a variety of psychiatric symptoms using DSM-III criteria, was revised repeatedly to improve 
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the bipolar disorders diagnostic section (Ambrosini, 2000; Geller et al., 2001). Structured and 
semi-structured clinical interviews adapted for the assessment of mania in youth aided 
researchers and clinicians in consistently identifying cases of PBD. 
Previously adult-focused self-report measures of mania were also adapted to facilitate 
youth and caregiver self-report. For example, a parent-report version of the Young Mania Rating 
Scale (P-YMRS) was developed and showed good discriminative validity in identifying cases of 
PBD compared to unipolar depression, disruptive behavior disorders, and other clinical 
diagnoses (Gracious, Youngstrom, Findling, & Calabrese, 2002). In addition to clinical 
interviews and rating scales, the importance of using setting-specific base rates and family 
history of BD as factors in evidence-based decision-making was instituted during this time 
period (Youngstrom, Findling, Kogos Youngstrom, & Calabrese, 2005). The introduction of 
effective screening tools and evidence-based assessment techniques may have led to more 
accurate identification of PBD cases, thereby impacting the rate at which PBD was diagnosed. 
Another potential outcome of evolving assessment methods is diagnostic substitution, 
which occurs when an individual diagnosed with ‘disorder A’ is later re-diagnosed with ‘disorder 
B,’ which takes the place of the original diagnosis. Diagnostic substitution is common among 
patients who receive an eventual BD diagnosis. Individuals with BD often experience long 
durations between receiving an initial psychiatric diagnosis (e.g., major depressive disorder) and 
receiving a diagnosis of BD (Hirschfeld et al., 2003; Lish, Dime-Meenan, Whybrow, Price, & 
Hirschfeld, 1994). With the advent of more effective screening measures between the mid-1990s 
to mid-2000s, many youths initially diagnosed with another psychiatric disorder may have 
experienced diagnostic substitution for a bipolar spectrum disorder upon re-evaluation, causing 
the rate of diagnosis of PBD to increase. However, mania typically onsets after depression 
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(Birmaher, Axelson, Strober, et al., 2009). Therefore, diagnostic substitution might also reflect 
the “typical” developmental onset of the disorder in which youth are initially diagnosed with 
depression but then later display symptoms of mania. During the period of diagnostic increase 
from the mid-1990s to mid-2000s, increased awareness and methods for detecting subthreshold 
mania symptoms may have increased the diagnostic transition from unipolar to bipolar 
depression. Since then, screening tools for PBD have been continuously refined. It is possible 
that with the development of more effective screening tools, cases of PBD may have been 
captured earlier in childhood or adolescence, potentially leading to a decrease in diagnostic 
switching over the past decade. 
Changes in Interventions. 
 The availability of pharmacological interventions for PBD also increased between the 
mid-1990s and mid-2000s. Findings from open-label trials and retrospective chart reviews 
suggested that mood stabilizing medications and second-generation antipsychotics may be 
effective in treating symptoms of PBD (Biederman et al., 2005; Frazier et al., 1999; Kowatch, 
Sethuraman, Hume, Kromelis, & Weinberg, 2003; Schreier, 1998). Placebo-controlled trials of 
pharmacological intervention for youth with PBD were also completed during this time with 
promising results (Kowatch et al., 2005). These interventions represented promising treatment 
options for youth with PBD receiving services in both inpatient and outpatient settings. 
Furthermore, compared to other countries, U.S.-based mental health providers may be 
incentivized to assign diagnoses if effective treatment options are available in order to receive 
reimbursement for services (Stringaris & Youngstrom, 2014). As the availability of 
pharmacological interventions for PBD increased, the rate at which clinicians were willing to 
provide a diagnosis of PBD may have increased between the mid-1990s to mid-2000s. However, 
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given evolving reimbursement practices and a potential decrease in public awareness of PBD, it 
is unknown whether youth continued to be referred for treatment at an increased rate over the 
past decade. 
Although the rate of change of PBD diagnosis has been assessed in Europe through 2013, 
potential changes in the rate of PBD diagnosis in the U.S. post-2004 have not been examined. 
Given the continued concern about overdiagnosis of PBD in the U.S., it is important to identify 
whether the rate of diagnosis of PBD has continued to change over the past decade. Therefore, 
the purpose of the current study was to examine the trajectory of PBD diagnosis after 2004 using 
national- and state-level inpatient data. 
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Chapter 2: Method 
Study 1. National Sample 
Data Source. 
Data for Study 1 included health information collected via the National Hospital 
Discharge Survey (NHDS) conducted annually by the National Center for Health Statistics 
(https://www.cdc.gov/nchs/data/series/sr_01/sr01_039.pdf). NHDS data is nationally 
representative based on a national probability sample of discharges from short-stay hospitals 
(i.e., average length of hospitalization less than 30 days for all patients) or general hospitals or 
children’s hospitals regardless of length of stay. Psychiatric hospitals are typically included 
under the short-stay hospital criteria. Hospitals were selected via three stages that are described 
in detail by Dennison and Pokras (2000). In the third stage, discharges were selected from each 
hospital using stratified random sampling for coding. The number of cases was between one and 
five percent of discharges with a minimum of 250 discharges annually. 
Data collected between 1996 and 2010 are de-identified and publicly available for 
download and analysis at the individual patient level. NHDS data includes patient diagnoses, 
age, gender, race, discharge year, geographic region, and type of insurance coverage. Each 
observation includes a weight that allows one to estimate the prevalence in the population (e.g., 
number per 10,000 persons). 
Statistical Analyses. 
All data analysis was conducted in R (R Core Team, 2013). Cases were limited to those 
with a primary diagnosis of a psychiatric disorder. This approach was used to exclude 
individuals hospitalized for physical health reasons who also have a psychiatric illness (e.g., a 
person hospitalized for an appendectomy who also had a diagnosis of major depressive disorder). 
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PBD was the focal diagnosis of all analyses. However, to better place the PBD findings in 
context, analyses were also repeated for youth with a primary diagnosis of a unipolar depressive 
disorder (DD) and for overall hospitalizations. Summing the weights of all cases in which a 
psychiatric disorder appeared as the primary diagnosis yielded an estimate of the total number of 
discharges from acute care facilities during the survey year. Dividing this estimated total number 
of discharges by the corresponding year’s U.S. population estimate for each age group permitted 
computation of annual hospitalization rates for children, adolescents, and adults. 
For PBD and DD, two indices were calculated from the NHDS data to represent rates of 
psychiatric diagnoses. Each index was computed for PBD and DD. The indices were: (a) 
proportion of psychiatric discharges with a primary diagnosis of PBD, and (b) the rate of PBD-
related discharges per 10,000 persons in the general population for the respective age group. For 
overall hospitalization trends, the following two indices were examined: (a) the proportion of all 
psychiatric hospitalizations relative to physical health hospitalizations and (b) the rate of 
psychiatric hospitalizations per 10,000 persons. Consistent with recommended practices, data 
were initially be screened for out-of-range values, plausible means and standard deviations, and 
univariate outliers (Tabachnick & Fidell, 2007).  
To examine the change in the proportion of youth being diagnosed with PBD, a series of 
chi-squared tests were conducted. To examine the overall trend in PBD diagnoses, the proportion 
from 1996 was compared to the proportion from 2010. To replicate Blader and Carlson (2007), 
the proportion of PBD cases from 1996 was compared to the proportion of PBD cases from 
2004. To test whether a change in proportion occurred, the proportion of cases from 2004 was 
compared to the proportion of cases in 2010. The analyses were repeated for proportions for DD 
and overall psychiatric hospitalization. 
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To test whether the population-adjusted rate of PBD diagnosis changed over time, a 
series of linear regression analyses with multiple predictors were conducted. Models were fit 
hierarchically to predict the rate of PBD diagnosis from survey year and age group. Age group 
was examined by using adolescents as the reference group in comparison with children and 
adults. The assumptions of regression (i.e., linear relationship, homogeneity of variance, and 
normality of residuals) were examined via a series of plots. Analyses were repeated for DD and 
overall psychiatric hospitalization. 
A series of logistic regressions were conducted that examine the ratio of PBD to other 
psychiatric hospitalization diagnoses. Models were fit hierarchically to predict PBD diagnosis 
from survey year, age, gender, race, U.S. region of the reporting facility, and type of health 
insurance coverage. Age group was examined by using adolescents as the reference group in 
comparison with children and adults. To examine gender, women were coded as 0 and men were 
coded as 1. Patients who identified as White were coded 0 and patients who identified as 
African-American were coded as 1. Government-funded insurance (e.g., Medicaid) was coded as 
0 and private insurance was coded as 1. Deviation coding was used to assess each geographic 
region (i.e., South, West, Midwest, and Northeast) compared to the mean of all geographic 
regions. This set of analyses was repeated for DD as well. 
Study 2. State-Level Sample 
Data Source. 
Data for Study 2 included Medicaid billing claims from five psychiatric inpatient 
hospitals in Nevada. De-identified billing claims were obtained from the Center for Health 
Information Analysis (https://chia.unlv.edu) and included claims for 48,108 unique inpatient 
admissions between 2005 and 2015 for youth ages five to 17. Diagnoses were reported for each 
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claim using ICD-9 codes. Mood disorder diagnoses were classified into two groups: 1) PBD or 
2) DD. PBD was classified using codes 296.00 - 296.06; 296.40 - 296.46; 296.50 - 296.56; 
296.60 - 296.66; 296.70; 296.80; 296.81; 296.89; and 301.13. DD was classified using codes 
296.20 - 296.26; 296.30 - 296.36; 300.4; 311.00; and 625.4. Additional variables in this dataset 
included gender, year, and hospital of admission. 
Statistical Analyses. 
Data were analyzed using the R statistical software. As in Study 1, PBD was the focal 
diagnosis of all analyses. To place the PBD findings in context for Study 2, analyses were again 
repeated for youth with primary diagnoses of DD. Admissions rates for each diagnostic group 
were converted to rate per 1,000 admissions per hospital per year. Linear regression was used to 
assess whether the rate of PBD diagnosis changed over time. Gender was subsequently added to 
the model to evaluate whether gender impacted the change in the rate of diagnoses over time, 
given that there are gender differences in the prevalence of mood disorders, particularly 
depression (Angst et al., 2002; Kuehner, 2003). A three-stage hierarchical multiple linear 
regression analysis was conducted to predict the rate of PBD diagnosis from year, gender, and 
the interaction between year and gender. An identical three-stage hierarchical regression model 
was conducted to evaluate the rate of diagnosis of DD. To ease the interpretation of the models, 
year was centered on 2005 so that data from 2005 had a year equal to 0, 2006 had a year equal to 
1, and so on. Gender was dummy coded as ‘0’ for males and ‘1’ for females.  
To account for clustering of diagnostic rates within hospitals over time, the cluster-
adjusted variance-covariance matrix was used to obtain estimates of the standard error, t-value, 
and significance value for each level of the regression models. The cluster-adjusted variance-
covariance matrix was also used to obtain the 95% confidence interval for the estimates of each 
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predictor. The F-statistic for each level of the models was obtained using the Wald test. R2 and 
the change in R2 were obtained from each of the original models, as R2 does not change even if 
the errors are clustered. R2 is calculated using the sums of squares, which become irrelevant once 
the variance-covariance matrix is used to account for clustering. However, R2 is still useful as a 
measure of goodness-of-fit even after using the corrected variance-covariance matrix to obtain 
new standard error and t-value estimates. 
The assumptions of regression (i.e., linear relationship, homogeneity of variance, and 
normality of residuals) were examined via a series of plots. Following visual examination of the 
data, the trend in diagnostic rates for the PBD and DD groups appeared nonlinear. As such, a 
second three-stage hierarchical multiple linear regression model was conducted to determine 
whether adding polynomial regression coefficients was meaningful. An identical model was 
conducted for the DD group. The cluster-adjusted variance-covariance matrix was again used to 
obtain estimates of the standard error, t-value, and significance value for each level of the 
regression models. R2 and the change in R2 were obtained for each level of the models to 
determine the overall variance accounted for after adding each polynomial regression coefficient. 
The F-statistic for each level of the model was obtained using the Wald test. 
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Chapter 3: Results 
Study 1. National Sample 
Changes in Proportions of Diagnoses. 
Between 1996 and 2010, 6.97% of all inpatient hospitalizations for individuals ages five 
and older were associated with a primary psychiatric diagnosis. The proportion of psychiatric 
hospitalizations initially increased from 6.76% in 1996 to 7.09% in 2004 (c2(1) = 23.36, p = 
.003) and decreased to 6.35% in 2010, c2(1) = 96.98, p < .001 resulting in a decline in the 
proportion of psychiatric diagnoses to overall hospitalizations between 1996 (6.76%) and 2010 
(6.35%), c2(1) = 24.41, p = .002. However, the overall proportion of psychiatric hospitalizations 
to all inpatient hospitalizations masks age-specific differences. Adults (> 18 years old) were most 
similar to the overall trajectory. For adults, psychiatric hospitalizations represented 6.50% of all 
adult hospitalizations in 1996 and this remained stable in 2004 at 6.64% (c2(1) = 3.96, p = .22) 
before declining to 5.72% in 2010, c2(1) = 149.07, p < .001. In contrast, both children (5-13 
years old) and adolescent (14-18 years old) proportions increased during the same time period. 
For adolescents, the proportion of psychiatric hospitalizations to all hospitalizations increased 
from 13.19% in 1996 to 18.97% in 2004 (c2(1) = 109.09, p < .001) and increased again to 
22.04% in 2010, c2(1) = 18.00, p = .009. The proportion of psychiatric hospitalizations for 
children grew from 7.55% of all child hospitalizations in 1996 to 9.72% in 2004 (c2(1) = 25.10, 
p < .001) and continued to increase to 16.12% in 2010, c2(1) = 106.09, p < .001. In summary, the 
overall decrease in the proportion of psychiatric diagnoses relative to all inpatient diagnoses was 
driven by a decrease in the adult psychiatric hospitalizations, while psychiatric hospitalizations 
increased for children and adolescents during the same time period. 
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Bipolar Disorder. 
Fourteen percent of all psychiatric hospitalizations were associated with a primary 
diagnosis of BD between 1996 and 2010. BD-related admissions increased from 9% of all 
psychiatric hospitalizations in 1996 to 15% in 2004 (c2(1) = 326.62, p < .001) and continued to 
increase to 17% in 2010, c2(1) = 11.65, p = .03. Figure 1 compares the proportions of all 
psychiatric hospitalizations with a diagnosis of BD, DD, or other non-mood disorder diagnoses 
by age group. Adults were again similar to the overall trajectory in BD diagnosis. The proportion 
of adult BD diagnosis increased from 9.21% of all adult psychiatric hospitalizations in 1996 to 
13.94% in 2004 (c2(1) = 181.85, p < .001), and continued to increase to 15.34% in 2010, c2(1) = 
11.30, p = .04. Adolescents were most similar to adults. The proportion of adolescent BD 
diagnosis increased from 8.56% of all adolescent psychiatric hospitalizations in 1996 to 22.46% 
in 2004 (c2(1) = 91.18, p < .001), and continued to increase to 27.93% in 2010, c2(1) = 9.36, p = 
.03. In contrast to the continued increase in BD diagnosis for adults and adolescents, the 
proportion of child BD diagnosis decreased between 2004 and 2010. The proportion of BD-
related hospitalizations increased from 8.31% of all child psychiatric hospitalizations in 1996 to 
32.23% in 2004 (c2(1) = 105.19, p < .001), then decreased to 19.54% in 2010, c2(1) = 24.29, p < 
.001. In summary, the continued increase in the proportion of BD diagnoses to all psychiatric 
diagnoses between 2004 and 2010 was largely driven by adults and adolescents, while the 
proportion of child BD diagnoses decreased during the same period. 
Depressive Disorders. 
The proportion of DD-related hospitalizations to all psychiatric hospitalizations between 
1996 and 2010 was 23%, which was not significantly different from the proportion of BD-related 
admissions during the same period, c2(1) = .04, p = .82. DD-related psychiatric admissions 
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increased significantly from 22% to 24% between 1996 and 2010, c2(1) = 12.80, p = .02. In 
contrast to BD, DD-related psychiatric hospitalizations initially remained relatively stable at 22% 
in both 1996 and 2004 (c2(1) = 1.96, p = .39), and then increased to 24% in 2010, c2(1) = 27.86, 
p = .001. Adults did not follow the overall trend in DD-related hospitalizations. The proportion 
of adult DD diagnosis relative to all adult psychiatric diagnoses remained stable over time at 
21.28% in 1996, 20.41% in 2004 (c2(1) = 3.06, p = .28), and 21.76% in 2010, c2(1) = 7.85, p = 
.10. The proportion of adolescent DD-related hospitalizations relative to all adolescent 
psychiatric hospitalizations followed a similar pattern. The proportion of adolescent DD 
remained stable at 29.42% in 1996, 33.42% in 2004 (c2(1) = 4.85, p = .13), and 38.39% in 2010, 
c2(1) = 6.34, p = .08. In contrast to adults and adolescents, the proportion of child DD diagnoses 
compared to all child psychiatric diagnoses decreased from 32.48% of all child psychiatric 
hospitalizations in 1996 to 20.32% in 2004 (c2(1) = 25.46, p < .001), followed by an increase to 
35.32% in 2010, c2(1) = 31.33, p < .001. The trend in the proportion of child DD diagnoses 
appears to have followed the opposite trend compared to child BD diagnoses. In summary, the 
mild increase in the overall proportion of DD diagnoses between 1996 and 2010 occurred despite 
relatively stable diagnostic practices in adults and adolescents. The diagnosis of DD in children 
was variable during this time period. 
Changes in Population-Adjusted Rates of Diagnoses. 
Table 1 displays population-adjusted rates of diagnoses by age between 1996 and 2010. 
Visual inspection of the longitudinal trajectory of population-adjusted rates of psychiatric 
diagnoses suggested a trend that could be nonlinear. Therefore, a series of regression models 
were fit hierarchically to test whether the change in the population adjusted rate of psychiatric 
hospitalization per 10,000 persons was nonlinear. Table 2 displays the hierarchical regression 
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results. Age group accounted for 77% of the variance in the population-adjusted rate of 
psychiatric hospitalizations, p < .001. Therefore, age group was controlled for in all analyses. 
After controlling for age group, year did not significantly predict the population-adjusted 
rate of psychiatric hospitalizations between 1996 and 2010, DR2 = .01, p = .27. Despite a 
significant improvement in model fit (DR2 = .02, p = .03), there was not a significant interaction 
between age and year. A significant quadratic effect for year indicated that the population-
adjusted rate of psychiatric hospitalizations increased between 1996 and 2006, followed by a 
slight decrease between 2006 and 2010, DR2 = .12, p < .001. However, the quadratic effect was 
moderated by age group, DR2 = .01, p < .001. As seen in Figure 2, the rate of psychiatric 
hospitalizations for children increased between 1996 and 2002 but remained relatively stable 
until 2010. The rate of psychiatric hospitalizations for adults increased mildly between 1996 and 
2006, but then declined below 1996 levels by 2010. The rate of psychiatric hospitalizations for 
adolescents increased rapidly between 1996 and 2006 before starting a decline through 2010. In 
summary, the adult and adolescent age groups experienced a period of initial increase in 
psychiatric hospitalizations followed by a decrease, while children experienced a period of initial 
increase followed by stabilization in psychiatric hospitalization rates. 
 Bipolar Disorder. 
Hierarchical regression models empirically tested whether the change in the population 
adjusted rate of BD-related hospitalizations per 10,000 persons was nonlinear. Table 3 displays 
the hierarchical regression results. Age group accounted for 59% of the variance in the 
population-adjusted rate of BD diagnosis, p < .001. Therefore, age group was controlled for in all 
analyses. 
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After controlling for age group, the population-adjusted rate of inpatient BD diagnosis 
increased mildly each year by .38 [.14, .61] diagnoses per 10,000 persons, DR2 = .08, p = .003. 
After controlling for the main effects of age group and year, there was not a significant 
interaction between age and year, DR2 = .02, p = .41. Adding a quadratic coefficient to year 
significantly improved overall model fit, DR2 = .11, p < .001. As seen in Figure 3, when 
controlling for age group, the population-adjusted rate of BD diagnosis increased between 1996 
and 2006, followed by a decrease between 2006 and 2010. After controlling for the main effects 
of age group, year, and year2, there was a trend toward a moderating effect of age group on the 
quadratic effect of year, DR2 = .03, p = .07. In summary, the rate of BD diagnosis per 10,000 
initially increased until the mid-2000s and then decreased through 2010 for all three age groups.  
 Depressive Disorders. 
Hierarchical regression models empirically tested whether the change in the population 
adjusted rate of DD-related hospitalization per 10,000 persons was nonlinear. Table 4 displays 
the hierarchical regression results. Age group accounted for 79% of the variance in the 
population-adjusted rate of inpatient DD diagnosis (p < .001) and was controlled for in all future 
analyses. 
After controlling for age group, year did not significantly predict the population-adjusted 
rate of inpatient DD diagnosis, DR2 = .00, p = .18. However, after controlling for main effects of 
age group and year, there was a significant interaction between year and the adult age group 
(DR2 = .04, p < .001), indicating that the change in the rate of diagnosis for adults was 
significantly different from the change in the rate of diagnosis for adolescents. The change in the 
rate of diagnosis for children over time did not significantly differ from adolescents. Adding a 
quadratic coefficient to year significantly improved overall model fit, DR2 = .15, p < .001. The 
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quadratic effect of year was moderated by age group, DR2 = .01, p = .003. As seen in Figure 4, 
the population-adjusted rate of inpatient DD diagnosis for children remained relatively stable 
between 1996 and 2002 and then increased until 2010. In contrast, the population-adjusted rate 
for adolescents increased between 1996 and 2003, then decreased until 2010. The rate of DD 
diagnosis among adults displayed a slight decrease across the study period. In summary, the 
population-adjusted rates of DD diagnosis were variable between age groups across the study 
period. 
Impact of Demographic Variables on Risk for Diagnoses. 
Bipolar Disorder. 
A series of logistic regression models examined the effect of demographic variables on 
BD diagnosis. The demographic variables considered included age group, gender, race, 
insurance type, and geographic region. Table 5 displays the results of the logistic regressions. 
Age group was examined by using adolescents as the reference group in comparison with 
children and adults. To examine gender, women were coded as 0 and men were coded as 1. 
Patients who identified as White were coded 0 and patients who identified as African-American 
were coded as 1. Government-funded insurance (e.g., Medicaid) was coded as 0 and private 
insurance was coded as 1. Deviation coding was used to assess each geographic region (i.e., 
South, West, Midwest, and Northeast) compared to the mean of all geographic regions.  
The first model examined the main effects of all demographic variables. After controlling 
for other demographic characteristics, adults were 43% less likely to receive a BD diagnosis than 
adolescents while children were not significantly different from adolescents in their risk for 
receiving a BD diagnosis. Compared to women, men were 34% less likely to be assigned a BD 
diagnosis. African-American individuals were 35% less likely to receive a BD diagnosis 
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compared to White individuals. Risk for BD diagnosis also varied by geographic region. 
Individuals living in the South and Midwest were 30% and 10% times more likely to receive a 
BD diagnosis compared to the average, respectively. In contrast, individuals living in the West 
were 20% less likely to receive a BD diagnosis compared to average. There was no difference in 
the odds of receiving a BD diagnosis by insurance type. In summary, race, gender, and 
geographic region altered an individual’s risk for BD, while insurance status did not affect risk. 
After controlling for main effects of all demographic variables, interactions between the 
demographic variables and time were examined. First, interactions between year and age group 
were assessed. The odds of receiving a BD diagnosis initially increased and then decreased at a 
more rapid rate for children compared to adolescents. In contrast, the odds of receiving a BD 
diagnosis increased and then decreased more slowly for adults relative to adolescents. Second, 
interactions between gender with year and age group were examined. Gender significantly 
interacted with the quadratic effect of year, such that the likelihood of receiving a BD diagnosis 
increased for both men and women until 2004, at which time it remained stable for women but 
decreased for men by 2010. There was no significant difference in the odds of BD diagnosis 
between boys and girls in the child age group, and this was not significantly different from the 
adolescent age group. However, adult men carried lower odds of receiving a BD diagnosis 
compared to adult women during the study period (Figure 5). In summary, the odds of receiving 
a BD diagnosis varied by age group throughout the study period. The odds of BD diagnosis by 
gender were significantly different between men and women in the adult age group. 
A third model evaluated interactions between year, race, and age group. The odds of 
receiving a BD diagnosis increased at a greater rate for African-American individuals across the 
study period compared to White individuals. There was also a significant interaction between 
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race and age group during the study period, such that African-American adults carried lower 
odds of BD diagnosis compared to African-American adolescents (Figure 6). In summary, race 
significantly interacted with both year and age group to impact the odds of BD diagnosis.  
A fourth model examined interactions between year, insurance type, and age group. 
There was a significant interaction between insurance type and year, such that such that the 
likelihood of receiving a BD diagnosis increased between 1996 and 2008 but remained stable 
between 2008 and 2010 for individuals insured through a government program. In contrast, the 
odds of BD diagnosis among privately insured individuals increased between 1996 and 2005, 
then decreased through 2010. Insurance type also interacted with age group (Figure 7), such that 
privately insured children were more likely to receive a BD diagnosis than their publicly insured 
counterparts, which differed from adolescents. In summary, the odds of receiving a BD diagnosis 
across the study period was impacted by significant interactions between insurance type, year, 
and age group. 
A final model assessed the interaction between year and geographic region. Geographic 
region significantly interacted with year, such that individuals in the South were 1.12 times more 
likely to be given a BD diagnosis compared to the average across the study period. In contrast, 
individuals in the West and Midwest were 13% and 3% less likely to receive a BD diagnosis, 
respectively. Geographic region also significantly interacted with the quadratic effect of year. 
The likelihood of BD diagnosis for those residing in the South significantly increased until 2006 
and then decreased through 2010. In contrast, the odds of BD diagnosis for those living in the 
West remained relatively stable until 2002 and then increased through 2010. Risk of BD 
diagnosis for individuals in the Midwest increased across the study period (Figure 8). In 
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summary, the odds of receiving a BD diagnosis significantly varied by geographic region 
throughout the study period. 
Depressive Disorders. 
Logistic regression models were repeated to examine the effect of demographic variables 
on DD diagnosis. Table 6 displays the results of the logistic regressions. Trends in the main 
effects of demographic variables on DD diagnosis were similar to the trends identified for BD. In 
particular, individuals in the adult age group were 34% less likely to receive a DD diagnosis 
compared to adolescents, while children did not significantly differ from adolescents in their risk 
for receiving a DD diagnosis. Compared to women, men were 41% less likely to be given a DD 
diagnosis. African-American individuals were 29% less likely to receive a DD diagnosis 
compared to White individuals. Individuals living in the South and Midwest were 1.2 and 1.4 
times more likely to receive a DD diagnosis compared to the average, respectively. In contrast, 
individuals living in the West were 33% less likely to be assigned a DD diagnosis compared to 
the average. In contrast with BD, privately insured individuals were 40% more likely to receive a 
DD diagnosis compared to their publicly insured counterparts. In summary, race, gender, 
geographic region, and insurance type altered an individual’s risk for DD. 
After controlling for main effects of all demographic variables, interactions between the 
demographic variables and year were examined. There were no significant interactions between 
year with gender, race, and age group. However, race significantly interacted with age, such that 
African-American adults carried a lower risk of receiving a DD diagnosis compared to African-
American adolescents (Figure 9). There was not a significant interaction between geographic 
region and year. Potential interactions between insurance type with year and age group were also 
examined. Insurance type interacted with year such that privately insured individuals carried 
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increased odds of DD diagnosis compared to publicly insured individuals. However, the odds of 
a privately insured person receiving a DD diagnosis decreased across the study period. Insurance 
type also interacted with age group such that privately insured adults were more likely to receive 
a DD diagnosis compared to privately insured adolescents (Figure 10). In summary, an 
individual’s risk for DD was significantly altered by the interaction between race and age group, 
as well as interactions between insurance type with year and age group. 
Study 2. State Sample 
 There were 48,108 unique inpatient admissions for youth ages five to 17 between 2005 
and 2015. Table 7 displays admissions counts and characteristics of the sample. The total number 
of pediatric inpatient hospitalizations for any psychiatric diagnosis increased from 3,140 to 7,728 
admissions between 2005 and 2015. Data from three hospitals were not available during all years 
between 2005 and 2009. However, data from all hospitals were available between 2010 and 
2015, during which time the overall number of pediatric hospitalizations increased from 4,659 to 
7,728. 
Bipolar Disorder. 
We initially hypothesized that the rate of PBD diagnosis significantly decreased between 
2005 and 2015. The rate of PBD diagnosis decreased from 207 to 111 per 1,000 admissions 
between 2005 and 2015. Visual inspection of the longitudinal trajectory of PBD diagnostic rates 
suggested a decrease between 2005 and 2015 that could be nonlinear. Therefore, three 
polynomial regressions were fit hierarchically to empirically test whether the change in PBD 
diagnostic rates was nonlinear. Table 8 displays the hierarchical regression results. Hospital of 
admission accounted for 17% of the variance in the rate of PBD diagnosis, F(4, 44) = 1.86, p = 
.14. Although not significant, hospital of admission was controlled for in all future analyses. 
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After controlling for hospital of admission, the rate of PBD diagnosis significantly 
decreased each year. Adding a quadratic or cubic coefficient did not significantly improve 
overall model fit. Both the quadratic and cubic effects trended toward a rapid decrease in PBD 
diagnosis with the cubic effect trending toward a slight increase in the final three years. Overall, 
the rate of PBD diagnosis declined between 2005 and 2015 (Figure 9). 
 A second hierarchical regression analysis examined the interaction between year and 
gender on the rate of PBD diagnosis over time. Table 9 displays the hierarchical regression 
results. When including gender in the dataset, hospital of admission significantly accounted for 
14% of the variance in the rate of PBD diagnosis. After controlling for hospital of admission, the 
rate of PBD diagnosis significantly decreased each year. After controlling for hospital of 
admission and year, gender was not associated with PBD diagnostic rates and there was not a 
significant interaction between year and gender. Therefore, the rate of diagnosis of PBD 
decreased between 2005 and 2015 for both boys and girls. 
Depressive Disorders. 
The rate of pediatric DD diagnosis increased from 284 to 429 per 1,000 admissions 
between 2005 and 2015. Visual inspection of the longitudinal trajectory of DD diagnostic rates 
suggested an increase between 2005 and 2015 that could be nonlinear. Therefore, three 
polynomial regressions were fit hierarchically to empirically test whether the change in DD 
diagnostic rates was nonlinear. Table 10 displays the hierarchical regression results. Hospital of 
admission significantly accounted for 44% if the variance in the rate of DD diagnosis. Therefore, 
hospital of admission was controlled for in all future analyses. 
After controlling for hospital of admission, the rate of DD diagnosis significantly 
increased each year. Adding a quadratic coefficient to the model indicated that the rate of DD 
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diagnosis significantly increased quadratically over time. Specifically, DD diagnostic rates 
decreased slightly between 2005 and 2008 and then increased dramatically between 2008 and 
2015. Adding a cubic coefficient did not significantly improve overall model fit. 
 A second hierarchical regression analysis examined the interaction between year and 
gender on the rate of DD diagnosis over time. Table 11 displays the hierarchical regression 
results. When including gender in the data set, hospital of admission significantly accounted for 
26% of the variance in the rate of DD diagnosis. After controlling for hospital of admission, 
year, and gender, there was a significant interaction between year and gender. Simple slopes 
analysis indicated that the slope of the rate of diagnosis for women (b = 13.03, p < .001) 
significantly increased while the slope of the rate of diagnosis for men (b = -.40, p = .87) 
remained stable over time. A final model examined the interaction between gender and the 
quadratic trend of year. Adding a quadratic coefficient significantly improved overall model fit, 
such that the rate of DD diagnosis for girls initially decreased between 2005 and 2008 followed 
by a dramatic increase between 2008 and 2015. Figure 10 displays the interaction between 
gender and the quadratic trend of year. 
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Chapter 4: Discussion 
The rate of PBD in the U.S. increased dramatically between the mid-1990s and mid-
2000s (Blader & Carlson, 2007; Harpaz-Rotem et al., 2005; Harpaz-Rotem & Rosenheck, 2004; 
Moreno et al., 2007), resulting in concern regarding the potential for overdiagnosis of PBD 
(Hirschfeld et al., 2003). However, given that the rate of PBD diagnosis had not been examined 
in the U.S. since 2004, the continued longitudinal trajectory of the rate of PBD diagnosis was 
unknown. Therefore, this study aimed to assess whether longitudinal changes in the rate of 
inpatient PBD diagnosis continued to occur subsequent to 2004. 
Blader and Carlson (2007) examined the rate of PBD diagnosis between 1996 and 2004 
using a nationally representative dataset of inpatient hospital admissions. Study 1 extended 
Blader and Carlson’s (2007) findings another 6 years to 2010 in order to assess whether the rate 
of national inpatient PBD diagnosis increased, decreased, or remained stable between 1996 and 
2010 with a particular focus on the period between 2004 to 2010. Study 2 utilized state-level data 
to lengthen the period under analysis to 2015. These extensions were important because in the 
mid-2000s scientific consensus developed around the intermediate diagnostic phenotype for PBD 
(Carlson & Glovinsky, 2009; Kowatch et al., 2005; Van Meter et al., 2016) which may have 
reduced the use of the broad PBD diagnostic phenotype in clinical practice. In addition, public 
awareness of PBD may have decreased after the mid-2000s (Fond et al., 2015). Therefore, we 
hypothesized that the rate of PBD diagnosis would decrease after 2004. 
As a proportion of all national psychiatric hospitalizations, BD diagnosis increased across 
the child, adolescent, and adult age groups until 2004. The proportion of BD diagnosis decreased 
among children from 2004 to 2010, while the proportion of BD diagnoses to all psychiatric 
hospitalizations increased among adolescents and adults during this period. In contrast to the 
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proportion of BD diagnosis to psychiatric hospitalizations, the population-adjusted rate of 
national BD-related hospitalizations significantly decreased from the mid-2000s until 2010 for 
all age groups. This trend was particularly notable for children, given that the population-
adjusted rate of overall psychiatric hospitalizations remained stable for children while the 
population-adjusted rate of PBD diagnosis declined. In summary, while BD diagnoses came to 
represent a greater proportion of inpatient psychiatric diagnoses among adolescents and adults 
across the study period, the rate of BD-related hospitalizations in the general population 
decreased from the mid-2000s to 2010 for all age groups. 
The availability of the national data ended in 2010. State-level inpatient data examined 
2005 to 2015 to provide a more recent window into inpatient psychiatric hospitalization 
diagnostic trends. State-level data indicated that the rate of PBD diagnosis significantly 
decreased among youth ages five to 17 between 2005 and 2015. However, youth ages five to 17 
were grouped together into a single age category to facilitate the de-identified nature of the data. 
It is therefore possible that trends in PBD diagnosis may be different between children and 
adolescents in the state-level data, and that one age group may be driving the decline in PBD 
diagnosis identified in our analyses.  
Our findings contrast with recent international estimates of trends in PBD diagnosis. For 
example, population-adjusted rates of PBD diagnosis among Danish youth increased between 
1995 and 2003 (similar to the trend in the U.S.). However, the Danish rate of PBD diagnosis 
continued to increase between 2004 and 2012 (Kessing, Vradi, & Andersen, 2014) in contrast to 
the apparent decrease in PBD diagnosis over a similar time period in the U.S. Results from 
German psychiatric inpatient units also contrasted with findings from the present study. In 
particular, the population-adjusted rate of inpatient diagnosis of PBD in Germany remained 
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stable among youth under age 15 from 2000 to 2013, but continuously increased for youth ages 
15 to 19 and adults across the study period (Holtmann et al., 2010; Rao et al., 2016). This 
contrasted with our data in which we observed significant initial increases followed by decreases 
in the population-adjusted rate of BD diagnosis for children, adolescents, and adults. These 
differences in diagnostic trends between countries also conflict with epidemiological data 
suggesting that there is no significant difference in the actual prevalence of PBD internationally. 
However, rates of clinical diagnosis of PBD appear to vary based on the diagnostic phenotype 
(e.g., broad vs. narrow) used to classify cases of PBD (Van Meter et al., 2011). Therefore, it is 
possible that discrepancies in rates of PBD diagnosis between the U.S. and other countries may 
be due to differences in diagnostic definitions used to classify PBD rather than a true difference 
in prevalence.  
In addition to identifying the longitudinal trajectory of PBD, the present study also aimed 
to compare it with the longitudinal trajectory of inpatient DD diagnosis. Results of Study 1 
indicated that the population-adjusted rate of DD diagnosis among adolescents in the U.S. 
initially increased until the mid-2000s and then decreased until 2010. However, DD diagnosis in 
U.S. children increased between the mid-2000s and 2010, while the rate of DD diagnosis in 
adults decreased across the study period. At the state level, the rate of DD diagnosis for boys 
remained stable between 2005 and 2015 but increased exponentially for girls between 2008 and 
2015. Internationally, increases in the inpatient diagnosis of depressive disorders have been 
identified among youth in the German national healthcare system. In particular, DD diagnosis 
increased by 832% among youth ages 0 to 19 (Holtmann et al., 2010; Rao et al., 2016). These 
findings suggest that longitudinal changes in diagnostic trends are not unique to PBD, and that 
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the rate of diagnosis of pediatric depressive disorders significantly increased over the same time 
period.  
A number of factors could have led to changes in the rate of inpatient PBD diagnosis. 
Significant concern about misdiagnosis of PBD (Hirschfeld et al., 2003) may have dissuaded 
clinicians from assigning the PBD diagnosis in the U.S. subsequent to the mid-2000s. Concern 
about overdiagnosis in particular may have resulted in diagnostic substitution, in which 
individuals initially diagnosed with PBD were later assigned a different psychiatric diagnosis. In 
the case of psychiatric conditions such as autism, diagnostic substitution has been implicated as 
one potential driver of change in rates of clinical diagnosis (Bishop, Whitehouse, Watt, & Line, 
2008). As rates of autism diagnosis have increased, rates of other developmental disorders, such 
as language disorders, have decreased (Bishop et al., 2008; Jick & Kaye, 2003). Vedel Kessing 
and colleagues (2015) examined the stability of PBD diagnosis among Danish youth between 
1994 and 2012 via a national register which allowed for the tracking of repeated psychiatric 
service contact for each patient. Some youth who did not receive a diagnosis of PBD at their 
initial contact with psychiatric services were later assigned a PBD diagnosis at subsequent points 
of contact. However, the opposite was also observed. In particular, of the youth who did receive 
a diagnosis of PBD at the initial point of contact, 21% experienced diagnostic substitution to 
other psychiatric disorders, such as major depression or schizophrenia, by the second point of 
contact (Vedel Kessing et al., 2015). It is possible that diagnostic substitution may have occurred 
similarly in the U.S. between PBD and other psychiatric diagnoses not included in the present 
study, which may have contributed to declining rates of PBD diagnosis. 
Another factor that may have resulted in declining rates of PBD diagnosis in the U.S. 
over the past decade relates to changes in public awareness about PBD. The initial increase in 
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PBD diagnosis from the mid-1990s to mid-2000s coincided with greater media and scientific 
coverage related to PBD (Lofthouse & Fristad, 2004). However, BD has been searched less often 
on the internet since the mid-2000s (Fond et al., 2015), it is possible that PBD is no longer at the 
forefront of public awareness. A decline in public awareness of PBD could have resulted in 
individuals being less likely to seek services related to PBD, leading to a decrease in clinical 
diagnosis. 
 Although diagnostic substitution and decreased awareness of PBD since the mid-2000s 
may have played a role in changing diagnostic rates, inpatient prevalence of PBD may have also 
been influenced by an increase in the availability of outpatient psychiatric services. By the mid-
2000s, the prevalence of outpatient office visits for BD had increased significantly in the U.S., 
with the majority of these youth and adults receiving pharmacological interventions at the 
outpatient level (Moreno et al., 2007). Interventions via outpatient care could have resulted in a 
decreased need for repeated hospitalizations for PBD over the past decade. However, one 
outpatient clinic in the U.S. identified a significant decrease in outpatient PBD diagnosis 
between 2008 and 2013 (Wesemann, 2016). Additional nationwide research is needed to 
determine whether there was a general trend toward increasing or decreasing outpatient service 
utilization, and whether this may have impacted the rate of inpatient PBD diagnosis. 
In addition to examining overall trends in diagnosis, exploratory aims of both Study 1 
and 2 included evaluating whether changes in the rate of PBD diagnosis significantly varied by 
demographic variables. Among youth, there was not a significant difference in the rate of PBD 
diagnosis by gender at the national or state levels suggesting that diagnostic rates of PBD were 
similar for boys and girls across the study period. However, in the national data, gender 
significantly interacted with year and the adult age group which suggested that adult men carried 
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lower odds of receiving a BD diagnosis compared to adult women across the study period. 
Findings from the present study contrast with earlier analyses that did identify gender differences 
in the rate of PBD diagnosis among youth specifically (Blader & Carlson, 2007; Moreno et al., 
2007). However, epidemiological findings disagree as to whether some symptoms of PBD may 
be more prevalent by gender. Some results indicate no gender differences in the actual 
prevalence of BD (Diflorio & Jones, 2010; Wozniak et al., 2013). Others suggest that some 
specific symptoms of PBD (i.e., increased energy, pressured speech, hyperactivity, grandiosity, 
and people-seeking) may be more common among boys than girls (Van Meter et al., 2016), 
which could contribute to differing diagnostic rates by gender in clinical practice if these 
symptoms were more noticeable to clinicians.  
While rates of BD diagnosis did not vary by gender among youth in our samples, other 
variables such as race, insurance type, and geographic region significantly interacted with year to 
predict BD diagnosis. In the U.S., previous analyses of clinical BD diagnosis have also observed 
such variations in diagnosis (e.g., Blader & Carlson, 2007). In the present study, differences in 
diagnostic rates by demographic variables were also observed in the DD group in both the state 
and national samples. These patterns persisted despite no identified differences in prevalence by 
most demographic variables in epidemiological research (Rowland & Marwaha, 2018; 
Weissman et al., 1996). Rather than a true difference in prevalence, this variability in diagnosis 
may be a result of disparities in access to mental health services across various demographic 
groups. For example, African-American and Hispanic individuals were less likely to receive 
treatment for mental health difficulties compared to white individuals between 1990 and 2003 
(Kessler et al., 2005). Furthermore, Hispanic and African-American individuals appear to have a 
greater likelihood of receiving clinical diagnoses of psychotic disorders compared to White 
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individuals. African-American individuals may be less likely to be diagnosed with a mood 
disorder compared to White individuals in clinical settings (Delphin-Rittmon et al., 2015). 
Mental health disparities among adults and youth may result from a number of factors that 
disproportionately affect minority groups, such as provider bias, discrepancies in access to care 
(Alegria, Vallas, & Pumariega, 2010; McGuire & Miranda, 2008), norms regarding treatment 
seeking behavior (Delphin-Rittmon et al., 2015), and socioeconomic status (Chow, Jaffee, & 
Snowden, 2003). Therefore, it is possible that the impact of demographics on the diagnosis of 
pediatric mood disorders may reflect broader trends in mental health disparities. 
Limitations 
While the present study provided evidence to suggest that the rate of PBD has decreased 
since the mid-2000s, the current data cannot be used to identify the precise reasons for why 
changes in inpatient diagnostic rates have occurred. Although there are a number of possible 
causes, the precise reason for why changes in the prevalence of clinical diagnoses occur can be 
difficult to ascertain. Further research is needed to determine the specific causes of changing 
trends in pediatric mood disorder diagnosis. Additionally, this study utilized de-identified billing 
data in which each data point represented a unique admission. Some individuals may have been 
repeatedly hospitalized throughout the study period and may contribute more than one unique 
admission to the data. Furthermore, the accuracy of administrative billing data for use in medical 
research has been questioned (Johnson & Nelson, 2013). Administrative billing data from 
medicine has sometimes indicated high agreement when compared to medical records or 
laboratory reference standards. For example, a systematic review of the utility of billing data to 
identify ventricular arrhythmias determined that the use of ICD-9 codes produced high positive 
predictive values when compared to patient medical records (Tamariz, Harkins, & Nair, 2012). 
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Administrative definitions of diabetes have also demonstrated high sensitivity and positive 
predictive values when compared to laboratory reference standards, though these values were 
dependent upon which administrative definition of diabetes was used (Southern et al., 2010). 
However, other findings have indicated that administrative billing databases may be prone to 
significant errors, such as data being incorrectly entered by hospital staff (Khwaja, Syed, & 
Cranston, 2002). Additionally, one administrative claims database of intracranial aneurysms 
demonstrated low specificity, sensitivity, and positive predictive value in identifying cases when 
compared to the neurosurgical departmental database (Woodworth, Baird, Garces-Ambrossi, 
Tonascia, & Tamargo, 2009). Although billing data is associated with limitations, it may still 
represent an effective means to obtain large samples in order to estimate trends in apparent 
service utilization (Johnson & Nelson, 2013). A further limitation of the present study is that 
findings from the state-level database are limited to a sample of Medicaid-insured youth. It is 
therefore unknown whether inpatient diagnosis of pediatric mood disorders have followed the 
same trends among privately insured youth at the state level. National data suggested that 
diagnostic rates for both PBD and DD may vary by type of insurance coverage (i.e., government-
funded vs. private insurance). Finally, only primary diagnoses were included in this study. It is 
therefore possible that rates of inpatient PBD diagnosis may be higher when ancillary diagnoses 
are considered to account for potential comorbidity. 
While results of the present study should be interpreted in light of limitations, they may 
provide valuable insight into changing trends in inpatient service utilization for BD in the U.S. 
Costs associated with the clinical management of BD are high among adults (Dean, Gerner, & 
Gerner, 2004; Stensland, Jacobson, & Nyhuis, 2007) and youth (Peele, Axelson, Xu, & Malley, 
2004). Individuals with BD are estimated to utilize significantly more resources on average when 
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compared to individuals with other psychiatric disorders (Peele et al., 2004; Stensland et al., 
2007). Therefore, awareness of the current diagnostic trends for BD may assist inpatient 
administrators and clinicians in preparing for anticipated service utilization and planning 
allocation of resources. Further research is necessary to evaluate continuously changing 
diagnostic rates and to determine the exact causes of changing trends in diagnosis across time. 
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Table 1 
 
Population-Adjusted Rates per 10,000 of Overall Psychiatric, BD, and DD Hospitalizations by Age and Year 
 
 Psychiatric Hospitalization BD-related Hospitalization DD-related Hospitalization 
Year Child Adolescent Adult Child Adolescent Adult Child Adolescent Adult 
1996 15.56 69.92 90.45 1.29 5.98 8.34 5.05 20.57 19.16 
1997 16.55 71.20 89.88 1.56 6.04 8.57 3.91 21.80 20.25 
1998 21.47 79.98 87.58 2.70 8.39 9.07 5.24 28.16 19.26 
1999 20.25 82.85 88.63 1.52 11.74 10.22 5.54 25.40 19.80 
2000 17.67 91.90 93.58 3.15 17.48 13.20 4.58 24.20 18.90 
2001 22.80 114.83 98.09 5.61 30.53 13.02 6.01 38.75 22.70 
2002 28.53 103.59 101.58 8.73 25.04 14.36 7.75 33.11 22.84 
2003 23.61 95.69 94.05 6.20 15.96 12.08 6.90 36.15 20.85 
2004 22.78 89.86 94.59 7.34 20.18 13.18 4.63 30.03 19.31 
2005 22.96 100.58 96.49 8.05 28.73 15.45 5.55 30.93 19.91 
2006 25.15 105.43 95.45 8.78 34.57 15.72 6.58 30.68 19.55 
2007 28.56 104.06 92.72 7.18 25.91 15.17 7.66 30.59 18.49 
2008 21.94 70.90 80.53 4.76 19.63 13.93 6.58 23.02 16.71 
2009 21.88 88.42 81.86 5.01 19.13 12.43 7.37 31.55 17.11 
2010 28.16 90.84 79.07 5.50 25.37 12.13 9.95 34.87 17.20 
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Table 2 
Hierarchical Regression of Model Fit for Population-Adjusted Psychiatric Hospitalization Predicted by Year 
Predictors Control b [95% CI] 
Linear 
b [95% CI] 
Year x Age Group 
b [95% CI] 
Quadratic 
b [95% CI] 
Year2 x Age Group 
b [95% CI] 
Constant 92.83* [86.26, 99.39] 
95.6712* 
[86.93, 104.41] 
86.42* 
[72.99, 99.84] 
75.63* 
[66.33, 84.92] 
67.67* 
[61.78, 73.55] 
Age Group      
     Child -69.61* [-76.45, -62.76] 
-69.54* 
[-76.76, -62.32] 
-67.59* 
[-81.31, -53.87] 
-67.84* 
[-78.32, -57.37] 
-51.35* 
[-57.66, -45.03] 
     Adult -1.51 [-8.82, 5.81] 
-1.59 
[-9.05, 5.87] 
8.78 
[-5.70, 23.26] 
9.80 
[.05, 19.54] 
18.11* 
[10.34, 25.89] 
Year  -.39 [-1.07, .29] 
.87 
[-.66, 2.41] 
5.32* 
[3.74, 6.89] 
8.60* 
[5.65, 11.55] 
Year x Child   -.29 [-1.86, 1.28] 
-.23 
[-1.51, 1.06] 
-6.99* 
[-10.13, -3.85] 
Year x Adult   -1.42 [-3.12, .28] 
-1.52* 
[-2.65, -.39] 
-4.96* 
[-8.24, -1.67] 
Year2    -.31* [-.39, -.22] 
-.54* 
[-.77, -.30] 
Year2 x Child     .47* [.22, .72] 
Year2 x Adult     .24 [-.01, .49] 
R2 .77 .78 .80 .92 .92 
F 734.60* 452.78* 385.00* 395.87* 594.39* 
ΔR2  .01 .02 .12 .00 
ΔF  281.82 67.78* 10.87* 198.52* 
Note. 95% CI = 95% confidence interval.  
* p < .05. 
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Table 3 
Hierarchical Regression of Model Fit for Population-Adjusted Rate of BD Predicted by Year 
Predictors Control b [95% CI] 
Linear 
b [95% CI] 
Year x Age Group 
b [95% CI] 
Quadratic 
b [95% CI] 
Year2 x Age Group 
b [95% CI] 
Constant 23.52* [19.70, 27.35] 
20.37* 
[16.06, 24.68] 
16.4480* 
[7.90, 25.00] 
11.08* 
[3.76, 18.40] 
2.74 
[-4.27, 9.76] 
Age Group      
     Child -17.12* [-14.51, -6.58] 
-17.12* 
[-14.19, -6.46] 
-11.75* 
[-20.71, -2.78] 
-11.87* 
[-19.36, -4.38] 
-3.54 
[-10.80, 3.71] 
     Adult -10.54* [-21.09, -13.16] 
-10.33* 
[-21.03, -13.21] 
-6.01 
[-14.76, 2.74] 
-4.78 
[-12.13, 2.57] 
4.37 
[-2.77, 11.51] 
Year  .38* [.14, .61] 
.85 
[-.06, 1.75] 
2.60* 
[1.66, 3.54] 
5.32* 
[2.90, 7.74] 
Year x Child   -.64 [-1.60, .31] 
-.65 
[-1.41, .12] 
-3.37* 
[-5.84, -.89] 
Year x Adult   -.52 [-1.46, .42] 
-.64 
[-1.40, .12] 
-3.68* 
[-6.14, -1.22] 
Year2    -.11* [-.15, -.07] 
-0.28* 
[-.45, -.12] 
Year2 x Child     .17* [.01, .34] 
Year2 x Adult     .19* [.03, .36] 
R2 .59 .67 .69 .80 .83 
F 62.90* 42.11* 27.90* 65.80* 63.07* 
ΔR2  .08 .02 .11 .03 
ΔF  20.79* 14.21 37.90* 2.73 
Note. 95% CI = 95% confidence interval.  
* p < .05. 
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Table 4 
Hierarchical Regression of Model Fit for Population-Adjusted Rate of DD Predicted by Year 
Predictors Control b [95% CI] 
Linear 
b [95% CI] 
Year x Age Group 
b [95% CI] 
Quadratic 
b [95% CI] 
Year2 x Age Group 
b [95% CI] 
Constant 30.31* [27.77, 32.85] 
31.14* 
[28.05, 34.24] 
26.90* 
[21.73, 32.08] 
24.39* 
[20.03, 28.74] 
22.05* 
[18.65, 25.45] 
Age Group      
     Child -23.72* [-26.41, -21.02] 
-23.68* 
[-26.51, -20.86] 
-22.46* 
[-27.72, -17.21] 
-22.44* 
[-27.30, -17.59] 
-16.99* 
[-20.51, -13.47] 
     Adult -10.73* [-13.44, -8.03] 
-10.78* 
[-13.54, -8.02] 
-5.82* 
[-11.22, -.42] 
-5.48* 
[-10.05, -.91] 
-3.01 
[-6.50, .49] 
Year  -.11 [-.27, .05] 
.46 
[-.05, .96] 
1.46* 
[.87, 2.05] 
2.39872* 
[.90, 3.90] 
Year x Child   -.18 [-.70, .34] 
-.17 
[-.72, .39] 
-2.38* 
[-3.95, -.80] 
Year x Adult   -.67* [-1.20, -.14] 
-.71* 
[-1.20, -.23] 
-1.70636* 
[-3.26, -.15] 
Year2    -.07* [-.10, -.04] 
-0.13* 
[-.26, -.01] 
Year2 x Child     .14966* [.02, .28] 
Year2 x Adult     .06813 [-.06, .19] 
R2 .79 .79 .83 .88 .89 
F 279.73* 155.40* 231.35* 145.67* 222.67* 
ΔR2  .00 .04 .05 .01 
ΔF  124.33 75.95* 85.68* 77.00* 
Note. 95% CI = 95% confidence interval.  
* p < .05. 
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Table 5 
 
Logistic Regression Predicting Odds of BD Diagnosis by Demographic Variables 
  Interaction of Demographic Variables with Year and Age Group 
 Main Effects Age Group Gender Race Insurance Type Geographic Region 
Predictor OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] 
     Constant .20 [.18, .22] * .12 [.10, .15] * .17 [.15, .19] * .19 [.17, .21] * .22 [.19, .26] * .23 [.20, .26] * 
     Year 1.13 [1.11, 1.15] * 1.26 [1.19, 1.34] * 1.11 [1.08, 1.14] * 1.12 [1.10, 1.15] * 1.08 [1.06, 1.11] * 1.08 [1.05, 1.11] * 
     Year2 .995 [.994, .996] * .99 [.99, .99] * .996 [.994, .998] * .995 [.994, .997] * .998 [.996, 1.00] .998 [.996, .999] * 
     Age Group       
          Child 1.11 [.98, 1.27] .70 [.48, 1.02] 1.13 [.92, 1.39] 1.17 [1.01, 1.35] * .95 [.79, 1.13] 1.12 [.98, 1.27] 
          Adult .57 [.53, .62] * .98 [.80 1.21] .69 [.62, .77] * .62 [.56, .68] * .54 [.48, .61] * .57 [.53, .62] * 
     Gender .66 [.63, .70] * .66 [.63, .70] * .92 [.77, 1.11] .66 [.63, .70] * .66 [.63, .70] * .66 [.63, .70] * 
     Race .65 [.61, .69] * .65 [.61, .69] * .65 [.61, .69] * .68 [.53, .86] * .65 [.61, .69] * .65 [.61, .69] * 
     Insurance Type 1.01 [.97, 1.06] 1.02 [.97, 1.07] 1.02 [.97, 1.07] 1.02 [.97, 1.07] .78 [.64, .94] * 1.02 [.97, 1.07] 
     Geographic Region       
          South 1.30 [1.25, 1.35] * 1.29 [1.24, 1.34] * 1.30 [1.25, 1.35] * 1.30 [1.25, 1.35] * 1.30 [1.25, 1.35] * .84 [.75, .94] * 
          West .80 [.75, .86] * .80 [.75, .86] * .80 [.75, .86] * .80 [.75, .86] * .80 [.75, .86] * 1.29 [1.06, 1.58] * 
          Midwest 1.11 [1.05, 1.17] * 1.11 [1.06, 1.17] * 1.11 [1.05, 1.16] * 1.11 [1.05, 1.17] * 1.11 [1.05, 1.17] * 1.05 [.92, 1.20] 
Interaction with Age       
     Child x Year  1.22 [1.09, 1.36] *     
     Adult x Year  .87 [.82, .93] *     
     Child x Year2  .99 [.98, .99] *     
     Adult x Year2  1.01 [1.00, 1.01] *     
Interaction with Gender       
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     Gender x Year   1.04 [1.00, 1.08]    
     Gender x Year2   .997 [.994, .999] *    
     Gender x Child   .88 [.68, 1.15]    
     Gender x Adult   .64 [.54, .75] *    
Interaction with Race       
     Race x Year    1.07 [1.01, 1.13] *   
     Race x Year2    .99 [.99, 1.00]   
     Race x Child    .75 [.56, 1.01]   
     Race x Adult    .65 [.54, .78] *   
Interaction with Insurance Type      
     Insurance x Year     1.10 [1.06, 1.15] *  
     Insurance x Year2     .992 [.990, .995] *  
     Insurance x Child     1.36 [1.05, 1.76] *  
     Insurance x Adult     1.10 [.94, 1.30]  
Interaction with Geographic Region      
     South x Year      1.12 [1.09 1.16] * 
     West x Year      .87 [.82, .93] * 
     Midwest x Year      .97 [.93, 1.02] 
     South x Year2      .994 [.992, .996] * 
     West x Year2      1.01 [1.00, 1.01] * 
     Midwest x Year2      1.00 [1.00, 1.01] * 
Nagelkerke R2 .025 .026 .026 .026 .026 .027 
ΔR2  .001 .001 .001 .001 .002 
Note. BD = Bipolar Disorder. OR = Odds Ratio. 95% CI = 95% confidence interval. ΔR2 = Change in Nagelkerke’s R2 between the main effects 
model and interaction effects models. 
* p < .05. 
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Table 6 
 
Logistic Regression Predicting Odds of DD Diagnosis by Demographic Variables 
  Interaction of Demographic Variables with Year and Age Group 
 Main Effects Age Group Gender Race Insurance Type Geographic Region 
Predictor OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI] 
     Constant .49 [.45, .53] * .45 [.38, .52] * .51 [.46, .57] * .47 [.43, .52] * .56 [.49, .63] * .47 [.43, .52] * 
     Year .98 [.96, .99] * .96 [.91, 1.02] .97 [.95, .99] * .98 [.961, .997] * .96 [.94, .98] * .98 [.96, 1.01] 
     Year2 1.00 [1.00, 1.00] * 1.00 [.999 1.01] 1.00 [.999, 1.002] 1.00 [1.00, 1.00] 1.003 [1.001, 1.004] * 1.00 [.999, 1.002] 
     Age Group       
          Child .89 [.79, 1.01] 1.05 [.81, 1.37] .89 [.74, 1.07] .83 [.73, .96] * .90 [.76, 1.07] .89 [.79, 1.01] 
          Adult .66 [.62, .71] * .72 [.61, .85] * .67 [.61, .74] * .83 [.73, .96] * .60 [.53, .67] * .67 [.62, .71] * 
     Gender .59 [.57, .61] * .59 [.56, .61] * .51 [.44, .60] * .59 [.57, .61] * .59 [.56, .61] * .59 [.57, .61] * 
     Race .71 [.68, .75] * .71 [.67, .75] * .71 [.68, .75] * .83 [.68, 1.01] .71 [.67, .75] * .71 [.68, .75] * 
     Insurance Type 1.39 [1.33, 1.44] * 1.39 [1.34, 1.45] * 1.39 [1.33, 1.44] * 1.39 [1.34, 1.45] * 1.10 [.93, 1.29] 1.39 [1.33, 1.45] * 
     Geographic Region       
          South 1.23 [1.19, 1.27] * 1.23 [1.20, 1.28] * 1.23 [1.19, 1.27] * 1.23 [1.19, 1.27] * 1.23 [1.19, 1.27] * 1.24 [1.14, 1.35] * 
          West .67 [.63, .71] * .67 [.63, .71] * .67 [.63, .71] * .67 [.63, .71] * .67 [.63, .71] * .60 [.51, .70] * 
          Midwest 1.36 [1.31, 1.42] * 1.36 [1.30, 1.42] * 1.37 [1.31, 1.43] * 1.37 [1.31, 1.43] * 1.36 [1.30, 1.42] * 1.37 [1.23, 1.52] * 
Interaction with Age       
     Child x Year  .91 [.83, 1.01]     
     Adult x Year  1.02 [.96, 1.08]     
     Child x Year2  1.01 [1.00, 1.01]     
     Adult x Year2  1.00 [.99, 1.00]     
Interaction with Gender      
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     Gender x Year   1.01 [.98, 1.05]    
     Gender x Year2   1.00 [.999, 1.003]    
     Gender x Child   .99 [.78, 1.27]    
     Gender x Adult   .98 [.85, 1.13]    
Interaction with Race       
     Race x Year    .99 [.95, 1.04]   
     Race x Year2    1.00 [.998, 1.005]   
     Race x Child    1.26 [.96, 1.65]   
     Race x Adult    .78 [.66, .93] *   
Interaction with Insurance Type      
     Insurance x Year     1.05 [1.01, 1.08] *  
     Insurance x Year2     .996 [.994, .999] *  
     Insurance x Child     .93 [.73, 1.19]  
     Insurance x Adult     1.20 [1.04, 1.39] *  
Interaction with Geographic Region      
     South x Year      1.00 [.97, 1.03] 
     West x Year      1.04 [.99, 1.09] 
     Midwest x Year      .99 [.95, 1.02] 
     South x Year2      1.00 [.998, 1.002] 
     West x Year2      1.00 [.994, 1.001] 
     Midwest x Year2      1.00 [.999, 1.004] 
Nagelkerke R2 .033 .033 .033 .033 .033 .033 
ΔR2       
Note. DD = Depressive Disorders. OR = Odds Ratio. 95% CI = 95% confidence interval. ΔR2 = Change in Nagelkerke’s R2 between the main 
effects model and interaction effects models. 
* p < .05. 
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Table 7 
 
Nevada Hospital Admissions Counts and Sample Characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 
Total Inpatient 
Admissions 3,140 2,551 2,256 2,302 3,356 4,659 4,784 4,865 5,871 6,596 7,728 
            
Gender            
     Men  
     n (%) 
1,686 
(54) 
1,349 
(53) 
1,617 
(72) 
1,276 
(55) 
1,730 
(52) 
2,513 
(54) 
2,423 
(51) 
2,440 
(50) 
2,763 
(47) 
3,216 
(49) 
3,294 
(43) 
     Women  
     n (%) 
1,454 
(46) 
1,202 
(47) 
639  
(28) 
1,026 
(45) 
1,626 
(49) 
2,146 
(46) 
2,361 
(49) 
2,425 
(50) 
3,108 
(53) 
3,380 
(51) 
4,434 
(57) 
Diagnosis            
     PBD  
     n (%) 
650  
(21) 
493  
(19) 
447  
(20) 
375  
(16) 
487  
(15) 
620  
(13) 
451  
(9) 
403  
(8) 
439  
(7) 
509  
(8) 
856  
(11) 
     DD  
     n (%) 
892  
(28) 
690  
(27) 
473  
(21) 
491  
(21) 
790  
(24) 
1,091 
(23) 
1,304 
(27) 
1,377 
(28) 
1,629 
(28) 
2,181 
(33) 
3,316 
(43) 
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Table 8 
Hierarchical Regression Analysis of Model Fit for PBD Diagnosis Predicted by Hospital and Year 
Predictors Control Model b [95% CI] 
Linear Model 
b [95% CI] 
Quadratic Model 
b [95% CI] 
Cubic Model 
b [95% CI] 
Constant 130.97* [109.91, 152.02] 
221.62* 
[175.09, 268.15] 
252.66* 
[181.15, 324.17] 
232.09* 
[150.00, 314.18] 
Hospital     
     1 -25.81* [-49.46, -2.16]  
-39.39* 
[-68.95, -9.82] 
-40.34* 
[-70.05, -10.63] 
-43.66* 
[-73.76, -13.56] 
     2 54.11 [-7.33, 115.54] 
40.53 
[-1.23, 82.29] 
39.57* 
[1.32, 77.82] 
36.25 
[-.01, 72.52] 
     3 -16.23 [-55.09, 22.62] 
-17.82 
[-38.18, 2.54] 
-17.33 
[-40.13, 5.48] 
-17.41 
[-39.14, 4.31] 
     4 3.48 [-27.02, 33.99] 
7.25 
[-24.96, 39.47] 
6.70 
[-20.86, 34.26] 
9.80 
[-17.63, 37.24] 
Year  -15.42* [-22.55, -8.29] 
-34.16* 
[-59.69, -8.62] 
7.46 
[-52.23, 67.16] 
Year2   1.82 [-.31, 3.95] 
-9.07 
[-21.86, 3.71] 
Year3    .72 [-.07, 1.50] 
R2 .17 .52 .57 .62 
F 1.86 5.43* 5.50* 7.86* 
ΔR2  .35 .05 .05 
ΔF  3.57* .07 2.36 
Note. 95% CI = 95% confidence interval.  
* p < .05. 
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Table 9 
Hierarchical Regression Analysis of PBD Diagnosis Predicted by Hospital, Year, Gender, and Year x Gender Interaction 
Predictors Control Model b [95% CI] 
Year 
b [95% CI] 
Main Effects of Year and 
Gender 
b [95% CI] 
Year x Gender Interaction 
b [95% CI] 
Constant 66.36* [57.64, 75.09] 
114.72* 
[92.86, 136.57] 
115.52* 
[89.17, 141.87] 
129.79* 
[92.03, 167.55] 
Hospital     
     1 -13.79* [-23.57, -4.00] 
-21.23* 
[-33.42, -9.03] 
-21.22* 
[-33.47, -8.97] 
-21.09* 
[-33.17, -9.01] 
     2 30.58* [3.07, 58.08] 
24.31* 
[3.63, 44.98] 
24.28* 
[3.67, 44.89] 
23.95* 
[3.99, 43.90] 
     3 -9.00 [-23.84, 5.85] 
-10.07* 
[-19.64, -.51] 
-10.06* 
[-19.69, -.44] 
-9.97 
[-20.24, .30] 
     4 .86 [-12.44, 14.16] 
2.63 
[-11.12, 16.37] 
2.63 
[-11.32, 16.59] 
2.72 
[-11.13, 16.56] 
Year  -8.18* [-11.31, -5.06] 
-8.18* 
[-11.31, -5.05] 
-10.69* 
[-15.83, -5.54] 
Gender   -1.67 [-16.83, 13.50] 
-30.85 
[-73.25, 11.55] 
Year * Gender    5.09 [-.90, 11.08] 
R2 .14 .41 .41 .44 
F 2.57* 6.84* 7.47* 6.30* 
ΔR2  .27 .00 .03 
ΔF  4.27* .63 1.17 
Note. 95% CI = 95% confidence interval.  
* p < .05. 
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Table 10 
Hierarchical Regression Analysis of Model Fit for DD Diagnosis Predicted by Hospital and Year 
Predictors Control Model b [95% CI] 
Linear Model 
b [95% CI] 
Quadratic Model 
b [95% CI] 
Cubic Model 
b [95% CI] 
Constant 313.41* [283.31, 343.52] 
225.42* 
[166.02, 284.82] 
306.34* 
[243.00, 369.69] 
300.17* 
[228.57, 371.77] 
Hospital     
     1  -112.18* [-147.23, -77.14] 
-99.01* 
[-140.55, -57.46] 
-101.50* 
[-146.43, -56.57] 
-102.49* 
[-148.94, -56.04] 
     2 18.43 [-30.79, 67.65] 
31.61 
[-13.97, 77.19] 
29.12 
[-6.63, 64.86] 
28.12 
[-8.35, 64.59] 
     3 34.00 [-42.70, 110.70] 
35.54 
[-23.59, 94.66] 
36.82 
[-12.56, 86.20] 
36.79 
[-13.13, 86.72] 
     4 -69.24 [-145.37, 6.89] 
-72.90* 
[-131.53, -14.27] 
-74.33* 
[-118.49, -30.18] 
-73.40* 
[-117.52, -29.29] 
Year  14.96* [4.74, 25.18] 
-33.90* 
[-59.84, -7.95] 
-21.41 
[-85.37, 42.55] 
Year2   4.74* [2.10, 7.38] 
1.47 
[-13.97, 16.91] 
Year3    .21 [-0.81, 1.24] 
R2 .44 .57 .70 .70 
F 20.34* 13.37* 20.52* 17.33* 
ΔR2  .13 .13 .00 
ΔF  6.97* 7.15* 3.19 
Note. 95% CI = 95% confidence interval.  
* p < .05. 
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Table 11 
Hierarchical Regression Analysis of DD Diagnosis Predicted by Hospital, Year, Gender, and Year x Gender Interaction 
Predictors Control Model b [95% CI] 
Year 
b [95% CI] 
Main Effects of  
Year and Gender 
b [95% CI] 
Linear  
Year x Gender 
Interaction 
b [95% CI] 
Quadratic  
Year x Gender 
Interaction 
b [95% CI] 
Constant 
160.33* 
[143.33, 177.33] 
122.93* 
[92.79, 153.08] 
-76.01* 
[45.42, 106.60] 
114.49* 
[86.21,142.78 
131.81* 
[92.72, 170.91] 
Hospital      
     1 -59.72* [-80.18, -39.25] 
-53.79* 
[-74.26, -33.31] 
-53.69* 
[-70.21, -37.18] 
-53.64* 
[-70.66, -36.62] 
-54.78* 
[-73.29, -36.28] 
     2 13.49 [-18.75, 45.73] 
18.52 
[-14.06, 51.10] 
20.85 
[-2.34, 44.04] 
19.69 
[-1.345, 40.74] 
18.56* 
[.49, 36.62] 
     3 23.59 [-11.02, 58.20] 
23.60 
[-7.84, 55.03] 
20.94 
[-2.06, 43.95] 
22.06* 
[.56, 43.55] 
22.49* 
[5.15, 39.82] 
     4 -38.25* [-75.96, -.54] 
-39.40* 
[-73.78, -5.01] 
-39.29* 
[-66.96, -11.62] 
-39.27* 
[-64.03, -14.52] 
-39.92* 
[-58.96, -20.88] 
Year  6.29* [.60, 11.98] 
6.28* 
[1.95, 10.61] 
-.40 
[-4.40, 3.60] 
-10.76 
[-23.70, 2.18] 
Gender   93.78* [71.24, 116.32] 
16.38 
[-31.62, 64.39] 
59.61* 
[8.75, 110.47] 
Year * Gender    13.43* [5.36, 21.49] 
-13.00 
[-33.66, 7.66] 
Year2     1.00 [-.09, 2.10] 
Year2 * Gender     2.57* [.48, 4.66] 
R2 .26 .30 .62 .68 .76 
F 10.76* 8.00* 28.17* 33.16* 38.32* 
ΔR2  .04 .32 .06 .08 
ΔF  2.76* 20.17* 4.99* 5.16* 
Note. 95% CI = 95% confidence interval.  
* p < .05. 
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Appendix B: Figures 
 56 
Figure 1 
 
Proportions of Mood Disorders Compared to All Adult Psychiatric Hospitalizations by Age 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Children Adolescents 
Adults 
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Figure 2 
Population-Adjusted Rate of Psychiatric Hospitalization by Age between 1996 and 2010 
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Figure 3 
Population-Adjusted Rate of BD-related Hospitalization by Age between 1996 and 2010 
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Figure 4 
Population-Adjusted Rate of DD-related Hospitalization by Age between 1996 and 2010 
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Figure 5 
 
Interaction between Gender and Age Group Predicting Odds of BD Diagnosis between 1996 and 2010  
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Figure 6 
Interaction between Race and Age Group Predicting Odds of BD Diagnosis between 1996 and 2010 
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Figure 7 
 
Interaction between Insurance Type and Age Group Predicting Odds of BD Diagnosis between 1996 and 2010 
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Figure 8 
 
Interaction between Geographic Region and Year Predicting Odds of BD Diagnosis between 1996 and 2010 
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Figure 9 
 
Interaction between Race and Age Group Predicting Odds of DD Diagnosis between 1996 and 2010  
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Figure 10 
 
Interaction between Insurance Type and Age Group Predicting Odds of DD Diagnosis between 1996 and 2010 
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Figure 11 
Diagnostic Rate of PBD per 1,000 Admissions between 2005 and 2015 by Hospital 
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Figure 12 
Interaction between Gender and Quadratic Effect of Year on the Rate of DD Diagnosis per 1,000 Admissions between 2005 and 2015
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goal of understanding how integrated health teams should function to better serve patients. 
 
Integrated Behavioral Health in Primary Care Course            Fall 2017 
Instructor: Sara Hunt, Ph.D. 
Sixteen-week course developed based on recommendations from the Interprofessional Education 
Collaborative for clinical professions who plan on delivering integrated behavioral health 
services. Areas of training included assessment, intervention, consultation, and working within 
an interdisciplinary team. Emphasis areas of the course included populations with complex needs 
in both physical and mental health (e.g., pediatric chronic pain patients). 
 
Regression Workshop               May 2017 
Instructor: Andrew J. Freeman, Ph.D. 
 89 
Comprehensive 6-day workshop on regression and use of R statistical programming for data 
analysis. 
 
Clinical Research Certificate              May 2015 
Research Administration and Training Series, University of Utah 
 
Certificate in Criminology and Corrections            May 2014 
College of Social and Behavioral Sciences, University of Utah 
 
 
PROFESSIONAL AFFILIATIONS 
 
Association for Psychological Science (APS), Student Affiliate              2017 – Present 
Association for Behavioral and Cognitive Therapies (ABCT), Student Member     2017 – Present 
American Psychological Association (APA), Student Member   2016 – Present 
American Psychological Association of Graduate Students (APAGS)   2016 – Present 
APA Division 53, Society of Clinical Child & Adolescent Psychology (SCCAP) 2015 – Present 
 
